Suppr超能文献

DOTA/DTPA 糖缀合物的 La(3+) 配合物与 RCA(120) 凝集素的相互作用:饱和转移差 NMR 光谱研究。

The interaction of La(3+) complexes of DOTA/DTPA glycoconjugates with the RCA(120) lectin: a saturation transfer difference NMR spectroscopic study.

机构信息

Department of Life Sciences, Center of Neurosciences and Cell Biology, University of Coimbra, Portugal.

出版信息

J Biol Inorg Chem. 2011 Jun;16(5):725-34. doi: 10.1007/s00775-011-0773-z. Epub 2011 Apr 3.

Abstract

The study of ligand-receptor interactions using high-resolution NMR techniques, namely the saturation transfer difference (STD), is presented for the recognition process between La(III) complexes of 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane monoamide and diethylenetriaminepentaacetic acid bisamide glycoconjugates and the galactose-specific lectin Ricinus communis agglutinin (RCA(120)). This new class of Gd(III)-based potential targeted MRI contrast agents (CAs), bearing one or two terminal sugar (galactosyl or lactosyl) moieties, has been designed for in vivo binding to the asialoglycoprotein receptor, which is specifically expressed at the surface of liver hepatocytes, with the aim of leading to a new possible diagnosis of liver diseases. The in vitro affinity constants for the affinity of the divalent La(III)-glycoconjugate complexes for RCA(120), used as a simple, water-soluble receptor model, were higher than those of the monovalent analogues. The combination of the experimental data obtained from the STD NMR experiments with molecular modelling protocols (Autodock 4.1) allowed us to predict the mode of binding of monovalent and divalent forms of these CAs to the galactose 1α binding sites of RCA(120). The atomic details of the molecular interactions allowed us to corroborate and supported the interaction of both sugar moieties and the linkers with the surface of the protein and, thus, their contribution to the observed interaction stabilities.

摘要

使用高分辨率 NMR 技术(即饱和转移差(STD))研究配体-受体相互作用,用于研究 La(III)配合物 1,4,7,10-四(羧甲基)-1,4,7,10-四氮杂环十二烷单酰胺和二乙烯三胺五乙酸双酰胺糖缀合物与半乳糖特异性凝集素蓖麻凝集素(RCA(120))之间的识别过程。这种新型基于 Gd(III)的潜在靶向 MRI 造影剂(CA),带有一个或两个末端糖(半乳糖基或乳糖基)部分,已被设计用于与在肝脏肝细胞表面特异性表达的糖蛋白受体结合,旨在导致新的可能诊断肝脏疾病。作为一种简单的水溶性受体模型,二价 La(III)-糖缀合物配合物与 RCA(120)的体外亲和常数对于 RCA(120)的亲和力高于单价类似物。从 STD NMR 实验获得的实验数据与分子建模方案(Autodock 4.1)的组合使我们能够预测这些 CA 的单价和二价形式与 RCA(120)的半乳糖 1α结合位点的结合方式。分子相互作用的原子细节使我们能够证实和支持两个糖部分和接头与蛋白质表面的相互作用,从而支持观察到的相互作用稳定性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验